SUMMERLIN HOSPITAL MEDICAL CENTER — History
CCN 290041 | 3-year financial timeline | COVID resilience: 52/100
🛡️ Public data only — no PHI permitted on this instance.
$450M
Latest Revenue (FY2022)
+3.8%
Revenue CAGR (3yr)
16.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $417M | $465M | $450M | -3.2% | +3.8% |
| Operating Expenses | $343M | $365M | $374M | +2.4% | +4.4% |
| Operating Margin | 17.8% | 21.5% | 16.9% | -21.2% | -2.6% |
| Net Income | $74M | $100M | $76M | -23.7% | +1.1% |
| Licensed Beds | 397 | 407 | 391 | -3.9% | -0.8% |
| Total Patient Days | 108,316 | 119,601 | 120,450 | +0.7% | +5.5% |
| Medicare Day % | 18% | 16% | 16% | -5.3% | -6.1% |
| Medicaid Day % | 8% | 8% | 9% | +19.1% | +7.4% |
COVID Impact & Recovery
Resilience Score: 52/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +7.8% ($417M → $450M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.8%
This Hospital
+7.6%
State Avg
Latest Margin
16.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $466M | 16.5% |
| FY2024 (proj) | $482M | 16.0% |
| FY2025 (proj) | $499M | 15.5% |